Related Experiment Video

Updated: Aug 13, 2026

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
08:04

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method

Published on: October 23, 2018

Positive and negative regulation of TSC2 activity and its effects on downstream effectors of the mTOR pathway

Jaroslaw Jozwiak1, Sergiusz Jozwiak, Tomasz Grzela

  • 1Department of Histology and Embryology, Center for Biostructure Research, Medical University of Warsaw, 02-004 Warsaw, ul. Chalubinskiego 5, Poland. jjozwiak@atdv.com.pl

Neuromolecular Medicine
|January 5, 2006
PubMed

Insights

Tuberous sclerosis involves mutations in TSC1/TSC2 tumor suppressor genes, affecting hamartin and tuberin proteins that regulate mTOR signaling. This review details TSC2 regulation by key cellular pathways like PI3K/Akt and Ras/MAPK.

Area of Science:

  • Genetics
  • Cellular Biology
  • Biochemistry

Background:

  • Tuberous sclerosis is an autosomal-dominant disorder linked to TSC1/TSC2 gene mutations.
  • Hamartin and tuberin proteins form complexes that inhibit mTOR kinase activity.
  • Tuberin regulates mTOR signaling via the Rheb GTPase, controlling cell proliferation.

Purpose of the Study:

  • To review recent findings on TSC2 regulation.
  • To elucidate the role of cellular signaling pathways in TSC2 function.
  • To understand the molecular mechanisms underlying tuberous sclerosis.

Main Methods:

  • Literature review of recent scientific publications.
  • Analysis of cellular signaling pathways impacting TSC2.
  • Focus on PI3K/Akt, Ras/MAPK, LKB1/AMPK, and REDD1 pathways.

Main Results:

  • TSC2 activity is modulated by phosphorylation and complex formation with hamartin.
  • Environmental cues like nutrient levels and stress influence TSC2 stability and mTOR activity.
  • Four major signaling pathways (PI3K/Akt, Ras/MAPK, LKB1/AMPK, REDD1) are identified as key regulators of TSC2.

Conclusions:

  • Understanding TSC2 regulation is crucial for tuberous sclerosis research.
  • Cross-talk between signaling pathways fine-tunes mTOR activity.
  • Recent advances provide new insights into TSC2-mediated cellular control.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...